Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4.

Collins PJ, McCully ML, Martínez-Muñoz L, Santiago C, Wheeldon J, Caucheteux S, Thelen S, Cecchinato V, Laufer JM, Purvanov V, Monneau YR, Lortat-Jacob H, Legler DF, Uguccioni M, Thelen M, Piguet V, Mellado M, Moser B.

FASEB J. 2017 Mar 30. pii: fj.201700013R. doi: 10.1096/fj.201700013R. [Epub ahead of print]

2.

Regulation of Chemokine Signal Integration by Activator of G-Protein Signaling 4 (AGS4).

Robichaux WG 3rd, Branham-O'Connor M, Hwang IY, Vural A, Kehrl JH, Blumer JB.

J Pharmacol Exp Ther. 2017 Mar;360(3):424-433. doi: 10.1124/jpet.116.238436. Epub 2017 Jan 6.

3.

CXC motif chemokine receptor 4 gene polymorphism and cancer risk.

Wu Y, Zhang C, Xu W, Zhang J, Zheng Y, Lu Z, Liu D, Jiang K.

Medicine (Baltimore). 2016 Dec;95(49):e5317. Review.

4.

CXCL12 protects pancreatic β-cells from oxidative stress by a Nrf2-induced increase in catalase expression and activity.

Dinić S, Grdović N, Uskoković A, Đorđević M, Mihailović M, Jovanović JA, Poznanović G, Vidaković M.

Proc Jpn Acad Ser B Phys Biol Sci. 2016;92(9):436-454.

5.

Optochemokine Tandem for Light-Control of Intracellular Ca2.

Feldbauer K, Schlegel J, Weissbecker J, Sauer F, Wood PG, Bamberg E, Terpitz U.

PLoS One. 2016 Oct 21;11(10):e0165344. doi: 10.1371/journal.pone.0165344. eCollection 2016.

6.

Sarcoplasmic reticulum Ca(2+) ATPase 2 (SERCA2) reduces the migratory capacity of CCL21-treated monocyte-derived dendritic cells.

Hong CY, Lee HJ, Choi NR, Jung SH, Vo MC, Hoang MD, Kim HJ, Lee JJ.

Exp Mol Med. 2016 Aug 19;48(8):e253. doi: 10.1038/emm.2016.69.

7.

Identification of gene expression patterns crucially involved in experimental autoimmune encephalomyelitis and multiple sclerosis.

Herrmann MM, Barth S, Greve B, Schumann KM, Bartels A, Weissert R.

Dis Model Mech. 2016 Oct 1;9(10):1211-1220. Epub 2016 Aug 12.

8.

Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy.

Cho BS, Zeng Z, Mu H, Wang Z, Konoplev S, McQueen T, Protopopova M, Cortes J, Marszalek JR, Peng SB, Ma W, Davis RE, Thornton DE, Andreeff M, Konopleva M.

Blood. 2015 Jul 9;126(2):222-32. doi: 10.1182/blood-2015-02-628677. Epub 2015 Jun 1. Erratum in: Blood. 2015 Aug 20;126(8):1049. Konoplev, Sergej [added].

9.

Upregulation of stromal cell-derived factor 1 (SDF-1) is associated with macrophage infiltration in renal ischemia-reperfusion injury.

Wan X, Xia W, Gendoo Y, Chen W, Sun W, Sun D, Cao C.

PLoS One. 2014 Dec 5;9(12):e114564. doi: 10.1371/journal.pone.0114564. eCollection 2014.

10.

Combined treatment with a CXCL12 analogue and antibiotics improves survival and neutrophil recruitment and function in murine sepsis.

Guan S, Guo C, Zingarelli B, Wang L, Halushka PV, Cook JA, Fan H.

Immunology. 2014 Sep 8. doi: 10.1111/imm.12382. [Epub ahead of print]

11.

Downmodulation of CCR7 by HIV-1 Vpu results in impaired migration and chemotactic signaling within CD4⁺ T cells.

Ramirez PW, Famiglietti M, Sowrirajan B, DePaula-Silva AB, Rodesch C, Barker E, Bosque A, Planelles V.

Cell Rep. 2014 Jun 26;7(6):2019-30. doi: 10.1016/j.celrep.2014.05.015. Epub 2014 Jun 5.

12.

Extracts from Curcuma zedoaria Inhibit Proliferation of Human Breast Cancer Cell MDA-MB-231 In Vitro.

Gao XF, Li QL, Li HL, Zhang HY, Su JY, Wang B, Liu P, Zhang AQ.

Evid Based Complement Alternat Med. 2014;2014:730678. doi: 10.1155/2014/730678. Epub 2014 May 5.

13.

Cell migration to CXCL12 requires simultaneous IKKα and IKKβ-dependent NF-κB signaling.

Penzo M, Habiel DM, Ramadass M, Kew RR, Marcu KB.

Biochim Biophys Acta. 2014 Sep;1843(9):1796-804. doi: 10.1016/j.bbamcr.2014.04.011. Epub 2014 Apr 18.

14.

Defective chemokine signal integration in leukocytes lacking activator of G protein signaling 3 (AGS3).

Branham-O'Connor M, Robichaux WG 3rd, Zhang XK, Cho H, Kehrl JH, Lanier SM, Blumer JB.

J Biol Chem. 2014 Apr 11;289(15):10738-47. doi: 10.1074/jbc.M113.515031. Epub 2014 Feb 26.

15.

The CXCR4 antagonist AMD3465 regulates oncogenic signaling and invasiveness in vitro and prevents breast cancer growth and metastasis in vivo.

Ling X, Spaeth E, Chen Y, Shi Y, Zhang W, Schober W, Hail N Jr, Konopleva M, Andreeff M.

PLoS One. 2013;8(3):e58426. doi: 10.1371/journal.pone.0058426. Epub 2013 Mar 6.

16.

Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases.

Montaner S, Kufareva I, Abagyan R, Gutkind JS.

Annu Rev Pharmacol Toxicol. 2013;53:331-54. doi: 10.1146/annurev-pharmtox-010510-100608. Epub 2012 Oct 22. Review.

17.

S1PR2 links germinal center confinement and growth regulation.

Green JA, Cyster JG.

Immunol Rev. 2012 May;247(1):36-51. doi: 10.1111/j.1600-065X.2012.01114.x. Review.

18.

Stromal-cell-derived Factor 1-α Promotes Tumor Progression in Colorectal Cancer.

Park SJ, Ahn TS, Cho SW, Kim CJ, Jung DJ, Son MW, Bae SH, Shin EJ, Lee MS, Kim CH, Baek MJ.

J Korean Soc Coloproctol. 2012 Feb;28(1):27-34. doi: 10.3393/jksc.2012.28.1.27. Epub 2012 Feb 29.

19.

Migration of Th1 lymphocytes is regulated by CD152 (CTLA-4)-mediated signaling via PI3 kinase-dependent Akt activation.

Knieke K, Lingel H, Chamaon K, Brunner-Weinzierl MC.

PLoS One. 2012;7(3):e31391. doi: 10.1371/journal.pone.0031391. Epub 2012 Mar 6.

20.

Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling.

Wojcechowskyj JA, Lee JY, Seeholzer SH, Doms RW.

PLoS One. 2011;6(9):e24918. doi: 10.1371/journal.pone.0024918. Epub 2011 Sep 20.

Supplemental Content

Support Center